Sigmund Rogich's most recent trade in BioVie Inc was a trade of 32,700 Common Stock done . Disclosure was reported to the exchange on Nov. 20, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
BioVie Inc | Sigmund Rogich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 32,700 | 36,926 (0%) | 0% | 0 | Common Stock | |
BioVie Inc | Sigmund Rogich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 22,070 | 22,070 | - | - | Stock Option (right to buy) | |
BioVie Inc | Rogich Sigmund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2023 | 42,254 | 42,254 (0%) | 0% | 0 | Common Stock | |
BioVie Inc | Sigmund Rogich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 55,000 | 55,000 | - | - | STOCK OPTION (RIGHT TO BUY) | |
BioVie Inc | Sigmund Rogich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 123,400 | 123,400 | - | - | Stock Option (right to buy) |